MARCHF9

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MARCHF9 mutation is significantly associated with the immune_cell of many other genes, with 4 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MARCHF9-associated genes across cancer lineages are B-cells, pDC, and Basophils. Each is linked with MARCHF9 in more than 1 cancer types. Because this analysis shows association rather than direction, both MARCHF9-to-partner and partner-to-MARCHF9 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, B-cells grouped by MARCHF9-low versus MARCHF9-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MARCHF9→partner) and Y-score (partner→MARCHF9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECB-cells →+0.054+1.895<.001.04831
UCECpDC →+0.061+2.815.030.03622
UCECBasophils →+0.333+3.000<.001.03721
UCECCMP →-0.038-2.989.032.03711
Each partner links to its Q-omics profile. Showing the 4 strongest of 4 associations by consensus.

B-cells by MARCHF9 expression — UCEC

Box plot of B-cells in MARCHF9-low vs MARCHF9-high samples in UCEC.

Explore this box plot interactively →

Exploration